Literature DB >> 26600967

Starring role of toll-like receptor-4 activation in the gut-liver axis.

Simone Carotti1, Michele Pier Luca Guarino1, Umberto Vespasiani-Gentilucci1, Sergio Morini1.   

Abstract

Since the introduction of the term "gut-liver axis", many studies have focused on the functional links of intestinal microbiota, barrier function and immune responses to liver physiology. Intestinal and extra-intestinal diseases alter microbiota composition and lead to dysbiosis, which aggravates impaired intestinal barrier function via increased lipopolysaccharide translocation. The subsequent increased passage of gut-derived product from the intestinal lumen to the organ wall and bloodstream affects gut motility and liver biology. The activation of the toll-like receptor 4 (TLR-4) likely plays a key role in both cases. This review analyzed the most recent literature on the gut-liver axis, with a particular focus on the role of TLR-4 activation. Findings that linked liver disease with dysbiosis are evaluated, and links between dysbiosis and alterations of intestinal permeability and motility are discussed. We also examine the mechanisms of translocated gut bacteria and/or the bacterial product activation of liver inflammation and fibrogenesis via activity on different hepatic cell types.

Entities:  

Keywords:  Chronic hepatitis; Dysbiosis; Gut microbiota; Gut motility; Intestinal barrier function; Lipopolysaccharide tolerance; Liver fibrosis; Non-alcoholic fatty liver disease; Toll-like receptor 4

Year:  2015        PMID: 26600967      PMCID: PMC4644892          DOI: 10.4291/wjgp.v6.i4.99

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  112 in total

1.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

2.  Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage.

Authors:  F Ammoscato; A Scirocco; A Altomare; P Matarrese; C Petitta; B Ascione; R Caronna; M Guarino; M Marignani; M Cicala; P Chirletti; W Malorni; C Severi
Journal:  Neurogastroenterol Motil       Date:  2013-10-01       Impact factor: 3.598

3.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

4.  Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.

Authors:  M Fornai; C Blandizzi; R Colucci; L Antonioli; N Bernardini; C Segnani; B Baragatti; S Barogi; P Berti; R Spisni; M Del Tacca
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease?

Authors:  Lorenza Conterno; Francesca Fava; Roberto Viola; Kieran M Tuohy
Journal:  Genes Nutr       Date:  2011-05-11       Impact factor: 5.523

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

7.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

8.  Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related molecules in cultured biliary epithelial cells.

Authors:  Kenichi Harada; Shusaku Ohira; Kumiko Isse; Satoru Ozaki; Yoh Zen; Yasunori Sato; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

9.  Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD.

Authors:  Umberto Vespasiani-Gentilucci; Simone Carotti; Giuseppe Perrone; Chiara Mazzarelli; Giovanni Galati; Andrea Onetti-Muda; Antonio Picardi; Sergio Morini
Journal:  Liver Int       Date:  2014-04-05       Impact factor: 5.828

Review 10.  Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks.

Authors:  Guido Carpino; Anastasia Renzi; Paolo Onori; Eugenio Gaudio
Journal:  Int J Mol Sci       Date:  2013-10-09       Impact factor: 5.923

View more
  18 in total

Review 1.  Gut Microbiota: Modulation of Host Physiology in Obesity.

Authors:  Vandana Nehra; Jacob M Allen; Lucy J Mailing; Purna C Kashyap; Jeffrey A Woods
Journal:  Physiology (Bethesda)       Date:  2016-09

2.  Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.

Authors:  Lauren K Barron; James W Bao; Bola G Aladegbami; Jason J Colasanti; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2017-03-16       Impact factor: 2.545

3.  Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Omid Ghamarnejad; Mohammedsadegh Nikdad; Pascal Probst; Katrin Hoffmann
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

Review 4.  Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.

Authors:  Tao Zhang; Kewei Sun; Ya Wang; Lei Huang; Ren Lang; Wei Jiang
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 2.586

Review 5.  Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Flavia A Cimini; Ilaria Barchetta; Simone Carotti; Laura Bertoccini; Marco G Baroni; Umberto Vespasiani-Gentilucci; Maria-Gisella Cavallo; Sergio Morini
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

Review 6.  Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Authors:  Pratima Dibba; Andrew A Li; Brandon J Perumpail; Nimy John; Sandy Sallam; Neha D Shah; Waiyee Kwong; George Cholankeril; Donghee Kim; Aijaz Ahmed
Journal:  Diseases       Date:  2018-09-19

7.  Alteration in gut microbiota caused by time-restricted feeding alleviate hepatic ischaemia reperfusion injury in mice.

Authors:  Jinjun Ren; Dandan Hu; Yilei Mao; Huayu Yang; Wenjun Liao; Wei Xu; Penglei Ge; Hongbing Zhang; Xinting Sang; Xin Lu; Shouxian Zhong
Journal:  J Cell Mol Med       Date:  2018-12-26       Impact factor: 5.310

Review 8.  Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders in Adults.

Authors:  Michele Pier Luca Guarino; Annamaria Altomare; Sara Emerenziani; Claudia Di Rosa; Mentore Ribolsi; Paola Balestrieri; Paola Iovino; Giulia Rocchi; Michele Cicala
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

Review 9.  Gut⁻Liver Axis: How Do Gut Bacteria Influence the Liver?

Authors:  Peter Christopher Konturek; Igor Alexander Harsch; Kathrin Konturek; Monic Schink; Thomas Konturek; Markus F Neurath; Yurdaguel Zopf
Journal:  Med Sci (Basel)       Date:  2018-09-17

10.  SCARF-1 promotes adhesion of CD4+ T cells to human hepatic sinusoidal endothelium under conditions of shear stress.

Authors:  Daniel A Patten; Sivesh K Kamarajah; Joanne M Rose; Joseph Tickle; Emma L Shepherd; David H Adams; Chris J Weston; Shishir Shetty
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.